Know Cancer

or
forgot password

Outlook: An Intervention to Improve Quality of Life in Serious Illness Study


N/A
18 Years
N/A
Open (Enrolling)
Both
Cancer, Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), End Stage Renal Disease (ESRD)

Thank you

Trial Information

Outlook: An Intervention to Improve Quality of Life in Serious Illness Study


This is a randomized control trial to evaluate the feasibility of the Outlook intervention.
225 veterans with advanced cancer, Congestive Heart Failure (CHF) or chronic obstructive
pulmonary disease (COPD) or end stage renal disease will be randomly assigned to one of
three intervention groups and complete a brief battery of pre-test measures. Subjects in the
first group ("treatment") will meet with a facilitator three times for a period of 45 min-1
hour. In the first session, subjects will be asked to discuss issues related to life review.
In the second session, participants will be asked to speak in more depth about issues such
as regret, forgiveness and things left undone, In the final session, subjects will focus on
heritage and legacy. The subjects in the second group ("attention control") will meet with a
facilitator three times for a period of 45 min- 1 hour and listen to a non-guided relaxation
CD. The third group of participants ("true control") will be exposed to no intervention or
attention control. One week and two weeks later, participants in all groups will receive
post-test measures administered by a blinded interviewer.


Inclusion Criteria:



- Patients with advanced cancer

- Congestive heart failure

- COPD

- End stage renal disease

Exclusion Criteria:

- Cognitive impairment

- inability to speak

- non-English speaking

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)

Outcome Measure:

Quality of Life

Outcome Time Frame:

8 weeks

Safety Issue:

No

Principal Investigator

Karen E. Steinhauser, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Durham VA Medical Center HSR&D COE

Authority:

United States: Federal Government

Study ID:

IIR 10-050

NCT ID:

NCT01044290

Start Date:

January 2011

Completion Date:

April 2014

Related Keywords:

  • Cancer
  • Congestive Heart Failure (CHF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • End Stage Renal Disease (ESRD)
  • quality of life
  • end of life
  • self-disclosure
  • Heart Failure
  • Kidney Diseases
  • Kidney Failure, Chronic
  • Lung Diseases
  • Respiration Disorders
  • Pulmonary Disease, Chronic Obstructive
  • Lung Diseases, Obstructive

Name

Location

Durham VA Medical Center HSR&D COE Durham, North Carolina  27705